Skip to main content
. 2023 Oct 24;2023(10):CD014722. doi: 10.1002/14651858.CD014722.pub2

Yang 2022.

Study characteristics
Methods Study design: RCT
Duration of study: the study was conducted from June to December 2019.
Country: China
Income classification: upper‐middle income country in 2019
Geographical scope: Zhejiang province
Healthcare setting: nursing home in Zhejiang province
Participants 1. Age: patients aged 65 years or more (average age: 85.36 years); caregivers not specified
2. Gender: both
3. Socioeconomic background: 68.85% blue‐collar workers, 71.31% living alone
4. Educational background: 31.71% illiterate, 30.89% primary education level (1‐6 years), 17.07% middle education level (7‐12 years), 20.33% high education level (> 13 years)
Inclusion criteria (Alzheimer's patients):
a. aged 65 years or more;
b. diagnosed as AD by NIA‐AA criteria;
c. lived in the selected nursing homes;
d. agreed with participating in the project.
Exclusion criteria (Alzheimer's patients):
a. consciousness disorders;
b. serious suicidal tendency;
c. deaf;
d. unable to communicate;
e. serious disability leaving the patient unable to participate in activities.
Participation suspension if:
f. unwilling to continue;
g. severe physical diseases after enrolment;
h. leaving nursing homes (or other violations of inclusion criteria).
Note: at baseline, the intervention and control group scores for Degree of Distress were, respectively, 1.72 (2.87) and 1.23 (2.30).
Stated purpose: to investigate if a multisectoral comprehensive intervention would improve the life quality of elderly patients with Alzheimer Disease and their caregivers
Interventions Name: comprehensive intervention (multisectoral Cooperative Care Model)
Title/name of PW and number: a multisectoral cooperative medical team including neurologists, nurses, patients’ caregivers, family members, rehabilitation therapists and social workers
1. Selection: not specified
2. Educational background: not specified
3. Training: only caregivers received a specific training (36 hours of systematic training) by the nursing staff.
4. Supervision: not specified
5. Incentives/remuneration: not specified
Prevention type: selective—participants were included based upon the presence of a risk factor (caregivers of Alzheimer's patients) and presented with some level of distress as indicated by the Degree of Distress scores that were below the cut‐off for the measure.
Intervention details: multisectoral co‐operative comprehensive intervention (in addition to routine intervention) was mainly divided into five parts: (a) self‐care training to slow down the functional degradation—activities including dressing up, folding clothes, making food, led by caregivers through daily life; (b) exercise rehabilitation—stretching, walking and other exercises conducted by physical therapists twice a week; (c) cognitive memory—games, conducted by rehabilitation therapists two to four times a week; (d) social interest—activities including writing calligraphy, finger painting, reading newspapers and so on were conducted by nursing staff four to five times a week; (e) nursing training (for the patients’ caregivers, rehabilitation therapists and nurses)—gave them systematic training about self‐health knowledge and problem behaviour processing skills, combined with mental behaviour problems treatment, in order to reduce the pressure on caregivers and improve their nursing ability.
Control: usual care (the control group was given routine intervention treatment in accordance with medical advice, which mainly included drug intervention and health education, and their caregivers were given basic health consultation services)
Outcomes Participants’outcomes of interest for this review
  1. Quality of life – QOL‐AD scale

  2. Distress/PTSD symptoms – Degree of Distress

  3. Social outcomes (social support) – Functional Social Support Scale


Carers’outcomes of interest for this review
Nil
Economic outcomes
Nil
Time points: baseline, post‐intervention (1‐6 months)
Notes Source of funding: National Science Foundation for Young Scientists of China (81803314), General project of Medical Science and Technology in Zhejiang province (2019KY001 and 2018KY193)
Notes on validation of instruments (screening and outcomes): for QOL‐AD – Zhang Huimin and colleagues translated QOL‐AD scale into a Chinese version with Cronbach's α coefficient of 0.835, and it was 0.814 and 0.717 in this study for patients and caregivers, respectively (Liu 2012).
Additional information: none
Handling the data: not applicable
Prospective trial registration number: ChiCTR1900023777 (China Clinical Trial Registration Center (CciCTR))